Today: 10 June 2026
Browse Category

ADX:FAB 1 March 2026 - 7 March 2026

Abu Dhabi Securities Exchange (ADX) loses more than 5% in three-session week after rare halt

Abu Dhabi Securities Exchange (ADX) loses more than 5% in three-session week after rare halt

Abu Dhabi’s main stock index closed Friday down 1.4%, ending the week more than 5% lower after a rare two-day shutdown following missile and drone strikes in the UAE. Heavy selling hit Aldar Properties, Abu Dhabi Commercial Bank, and Emirates Telecommunications Group. The exchange imposed a 5% daily loss limit and urged companies to disclose any material impact. Dubai’s market dropped 3.2% Friday and 9% for the week.
7 March 2026
·······

Stock Market Today

  • U.S. Stock Futures Fall Amid Iran Strikes and Inflation Concerns
    June 10, 2026, 9:04 AM EDT. Nasdaq futures declined over 1% as former President Donald Trump warned of further actions against Iran following recent strikes. Investors also braced for upcoming Consumer Price Index (CPI) data, with economists forecasting inflation to surpass a critical threshold. The developments heightened market jitters, impacting investor sentiment ahead of key economic releases.

Latest articles

BlackBerry Drops Again; QNX Gains on the Line With June Earnings Ahead

BlackBerry Drops Again; QNX Gains on the Line With June Earnings Ahead

10 June 2026
BlackBerry shares dropped 4.84% to $8.84 Tuesday and slid further to $8.42 premarket Wednesday, erasing part of a 49% rally as investors question whether QNX and Secure Communications growth can justify recent gains ahead of Q1 fiscal 2027 earnings on June 25; the stock is now down 14.5% from last week’s close.
Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

10 June 2026
Nuvalent soared 39.28% to $123.25 after GSK agreed to buy the company for $124 per share in cash, leaving a narrow 0.6% spread as investors shift focus to the $10.6 billion merger’s tender-offer timing, antitrust review, and FDA decision dates for two lung-cancer drugs in September and November 2026.
Go toTop